Renhe Pharmacy Co., Ltd.

Sümbol: 000650.SZ

SHZ

6.57

CNY

Turuhind täna

13.8854
P/E suhe
3.1936
PEG suhe
9.20B
MRK Cap
0.03%
DIV tootlus

Renhe Pharmacy Co., Ltd. (000650-SZ) Finantsaruanded

Q: Mis on Renhe Pharmacy Co., Ltd. (000650.SZ) koguvara?

Renhe Pharmacy Co., Ltd. (000650.SZ) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Renhe Pharmacy Co., Ltd. (000650.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 1605.221 M, mis on 0.763 % gowth. Kogu perioodi keskmine brutokasum on 639.845 M, mis on 0.964 %. Keskmine brutokasumi suhtarv on 0.295 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.136 %, mis on võrdne -0.127 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Renhe Pharmacy Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.105. Käibevara valdkonnas on 000650.SZ aruandlusvaluutas 4580.859. Märkimisväärne osa neist varadest, täpsemalt 3242.35, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.212%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 119.532, kui neid on, aruandlusvaluutas. See näitab erinevust 55.055% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 5.793 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.938%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 5740.789 aruandlusvaluutas. Selle aspekti aastane muutus on 0.086%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 582.458, varude hind on 457.74 ja firmaväärtus 578.24, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 602.2.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995	1993
balance-sheet.row.cash-and-short-term-investments	12028.24	3242.3	2676	2168.8	2224.4	1764.1	1361.5	1051.9	816	640.8	544.4	455.2	266.3	289.3	358.2	129.1	79	47.7	3.7	42.6	105.5	151.9	129.1	117.7	142.4	53.7	36.9	71.6	1.1	3.7	2.9
balance-sheet.row.short-term-investments	5637.48	416.9	315.6	460.9	805.1	7.9	10	8.8	8.2	6.7	5.2	5.5	8.3	9.2	7.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	3217.73	582.5	647.3	501.6	563.2	597.8	549	485.9	568.9	477.1	463.3	458.3	686.6	632	253.6	177.5	95.5	57.9	117.7	157.8	172.6	211	207.1	111.9	33.1	91.3	89.7	44.6	9.1	3.6	3
balance-sheet.row.inventory	1806.76	457.7	601.4	451.7	522.9	533.1	455.9	457	369.1	303.4	251.7	201	160.3	138.8	38.7	27.8	17.8	62	40.8	86.4	84.4	68.8	63	78.9	37.3	41.2	1.3	13.9	26.9	23.4	20
balance-sheet.row.other-current-assets	1566.18	298.3	131	711.4	9.2	10.5	17.9	9.7	3	3.6	7.6	9.7	-8	-5.7	30.9	-35.1	-10.9	-27.3	-1.1	-2.5	-1.5	-1.6	-31.7	4.8	5.9	4.7	6	11.7	2.9	10.8	7.8
balance-sheet.row.total-current-assets	18618.91	4580.9	4055.7	3833.5	3319.7	2905.4	2384.3	2004.6	1757	1424.8	1267.1	1124.1	1105.3	1054.4	681.4	299.3	181.4	140.3	161.1	284.3	361	430.1	367.6	313.2	218.8	190.9	133.8	141.8	40	41.5	33.7
balance-sheet.row.property-plant-equipment-net	4986.1	1240.7	1111.6	744	629.8	631.8	679.7	721.6	649.3	559	527.4	452.3	222.5	155.7	123.9	24.5	25	24.3	292.7	314.4	318.4	329.5	344.3	338.2	257	168.6	143.6	127.8	130.8	131.3	96
balance-sheet.row.goodwill	2312.95	578.2	606.1	102.2	102.2	377.9	420	437.8	131.1	102.2	102.2	95.7	9.9	9.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2462.49	602.2	650.6	664.5	666.2	661.6	663.4	682	375.5	398.6	422.3	418.1	256.1	253.8	247.1	113.7	101.5	107	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	4775.44	1180.4	1256.8	766.7	768.4	1039.4	1083.4	1119.8	506.5	500.8	524.5	513.8	266	263.7	247.1	113.7	101.5	107	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	-3458.37	119.5	77.1	439.1	-599.8	5.1	-9.9	-8.5	-8	6.2	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	71.29	17.7	6.6	5.5	6.9	7.2	5.1	7.3	4.4	7.3	6.1	2.7	0.7	0.2	0.7	0.2	0.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	5902.29	492.4	400.2	516.3	859.6	27.7	24.7	20.1	247.1	99	2.6	2	8.3	4.2	7.8	0	0	0.2	2.2	2.1	0	0	0	0.2	0.4	0.6	0.8	0.2	0	0	0
balance-sheet.row.total-non-current-assets	12276.76	3050.8	2852.2	2471.6	1664.7	1711.3	1783.1	1860.3	1399.3	1172.3	1061.7	970.8	497.5	423.8	379.5	138.5	127.1	131.4	294.9	316.5	318.4	329.6	344.4	338.4	257.5	169.2	144.4	128	130.8	131.3	96
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	30895.67	7631.6	6907.9	6305.1	4984.4	4616.7	4167.4	3864.9	3156.3	2597.1	2328.7	2094.9	1602.8	1478.2	1060.9	437.8	308.5	271.7	456	600.7	679.4	759.7	711.9	651.6	476.2	360.1	278.2	269.7	170.8	172.7	129.7
balance-sheet.row.account-payables	1296.75	199.6	176.1	147.2	142.2	213.7	230.1	236.8	229.7	180.6	152.2	149.3	202.6	278.9	44.4	19.7	40.3	10.8	62.2	92.6	60.2	72.2	47.1	46.3	13.6	0.3	0.2	0.1	2.2	0	0
balance-sheet.row.short-term-debt	16.88	6.7	2.8	60.1	-74.1	0	0	0	0	0	0	0	20	20	0	0	0	0	312.3	316	217	156.3	104.3	24.3	14	31	25	25	23	0	0
balance-sheet.row.tax-payables	863.94	279.9	273.8	126.6	172	173.2	148.6	136.5	157.1	101.1	49.9	68.5	50.4	52.2	20.7	25.8	7.4	30.1	13.1	2.6	2.1	6.6	4.8	5.2	6.7	2.8	3.6	5.9	2.4	0	0
balance-sheet.row.long-term-debt-total	23.17	5.8	3.6	2.7	0	0	0	0	0.2	0.2	0	0	0	0	0	0	0	0	0	0	142.3	169.3	205.3	205.3	169.4	86.8	86.8	91.3	90.7	0	0
Deferred Revenue Non Current	154.4	38.8	8.3	9.4	8.8	10.1	11.4	13.6	15	17.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	2.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1205.38	603.6	51.5	42.1	481	477.3	452.9	409.3	308.6	235	218.5	214.5	151.4	189	159.3	112.5	32.7	66.3	3.8	2.2	4.3	4.1	3.9	6.7	2.7	0.3	0.4	1.4	0.2	37.3	30
balance-sheet.row.total-non-current-liabilities	180.38	45.3	12.3	9.8	9.3	10.6	11.9	14.3	17.2	19.4	19.2	19	18.5	0	0	0	0	0	2.6	2.9	143.2	169.8	205.6	205.3	169.4	86.8	86.8	91.3	90.7	86.8	86.8
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	-18.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	23.17	5.8	3.6	2.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	4461.31	1209.9	981	694.5	632.5	701.7	694.9	660.4	555.4	435.1	389.9	382.8	460.7	566.1	203.7	132.2	73	77	409.1	431.7	441.2	420.9	380.4	306.3	214.7	126.3	118.8	126.7	119.5	124.1	116.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	5599.75	1399.9	1399.9	1399.9	1238.3	1238.3	1238.3	1238.3	1238.3	990.7	990.7	990.7	630.2	420.2	280.1	220.1	220.1	200.1	200.1	200.1	200.1	200.1	200.1	111.2	102.7	85.6	78	52	11	11	11
balance-sheet.row.retained-earnings	13087.09	3142	2742.7	2412.6	2021	1607	1255.5	1017.2	685.3	590.7	401.3	230.7	417.7	392.8	261.2	4.6	-69.3	-104.7	-242.8	-119.1	-50	50.6	43.5	80.3	67.3	43.7	19.7	5.7	0	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	4012.01	415.3	390.6	307.1	254	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	783.55	783.6	754.1	953.3	292.3	546.2	514.7	496.3	465.4	451.5	434.5	399.4	69	61.1	315.1	80.9	84.7	99.3	89.6	88.1	88.1	88.1	88	153.9	91.5	104.4	61.8	85.3	40.3	37.7	1.9
balance-sheet.row.total-stockholders-equity	23482.4	5740.8	5287.2	5072.9	3805.6	3391.6	3008.5	2751.9	2389	2032.9	1826.4	1620.8	1116.9	874.1	856.4	305.6	235.4	194.7	46.9	169	238.2	338.7	331.6	345.3	261.5	233.8	159.4	143.1	51.3	48.7	12.9
balance-sheet.row.total-liabilities-and-stockholders-equity	30895.67	7631.6	6907.9	6305.1	4984.4	4616.7	4167.4	3864.9	3156.3	2597.1	2328.7	2094.9	1602.8	1478.2	1060.9	437.8	308.5	271.7	456	600.7	679.4	759.7	711.9	651.6	476.2	360.1	278.2	269.7	170.8	172.7	129.7
balance-sheet.row.minority-interest	2951.95	681	639.7	537.6	546.4	523.4	463.9	452.6	211.8	129.1	112.4	91.3	25.2	38	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	26434.35	6421.8	5926.9	5610.5	4352	3915	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	30895.67	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	2179.11	536.4	392.7	900	205.3	7.9	0.1	0.3	0.2	6.7	5.2	5.5	8.3	9.2	7.9	0	0	0.2	2.2	2.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	40.06	12.5	6.5	60.1	0	0	0	0	0	0	0	0	20	20	0	0	0	0	312.3	316	359.3	325.6	309.6	229.6	183.4	117.8	111.8	116.3	113.7	0	0
balance-sheet.row.net-debt	-6350.71	-2813	-2354	-1647.8	-1419.2	-1756.2	-1351.5	-1043.1	-807.8	-634	-539.2	-449.6	-238	-260	-350.3	-129.1	-79	-47.7	308.6	273.5	253.7	173.7	180.4	111.9	40.9	64.1	74.9	44.7	112.6	-3.7	-2.9

Rahavoogude aruanne

Renhe Pharmacy Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 2.774 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 0.000 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 182.28 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -575166939.980. See on -2.802 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 117.15, 0.29, -5.55, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -140.17 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -84.36, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999
cash-flows.row.net-income	658.36	711.6	799.9	657.7	619.3	584.1	441.2	430.8	435.6	323.9	216	276.1	305.8	225.7	165.5	70.2	39.2	130.3	-129.9	-69.1	-100.5	8.8	-12.7	21.8	27.7	28.3
cash-flows.row.depreciation-and-amortization	118.85	117.2	86.6	83.9	96.3	91.8	87.2	80.3	74.1	69	64.2	56.2	29.4	26.8	20.6	8.6	8.3	20.8	22.3	27.4	27.1	26.9	23.5	18.6	12.8	11.5
cash-flows.row.deferred-income-tax	-254.17	-10.8	-0.8	1.1	-1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	17.32	17.3	10.4	-1.1	1.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	238.73	410.2	-86.3	194.5	-34.3	-147.8	-18.3	33.2	-56.2	-17	-81	-138.9	-178.6	-129.8	13.4	-16.2	-12.9	389.4	-30.1	4.4	-100.4	-21.5	-14.4	-85.2	16.3	-35.6
cash-flows.row.account-receivables	127.1	127.1	-62.5	54.2	-107.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	111.63	111.6	-124.4	69.8	-25	-81.3	0.8	-61.9	-56.8	-53.4	-50.5	-33	-21.6	-41	4.5	-9.3	43.5	49.5	45.9	-3.1	-15.7	-5.2	15.6	-41.4	3.4	-28.9
cash-flows.row.account-payables	0	182.3	101.3	68.9	99	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-10.8	-0.8	1.7	-1.3	-66.5	-19.1	95	0.6	36.4	-30.4	-105.9	-157	-88.8	8.9	-6.9	-56.4	339.9	-76.1	7.5	-84.7	-16.3	-30	-43.8	12.9	-6.6
cash-flows.row.other-non-cash-items	-80.5	24.6	-32.1	-64.9	12.7	41.4	-12.2	-22.2	-18.8	-10.6	14.1	-9.5	10.3	7.4	1.1	-0.4	0.8	-305.3	120.1	54.9	123.6	13.8	7.1	7.8	10.6	10.2
cash-flows.row.net-cash-provided-by-operating-activities	698.58	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-197.29	-221.1	-499.8	-218.2	-144.1	-70.1	-43.6	-59.9	-77.4	-137.5	-94.1	-242.1	-101.5	-28.6	-58.5	-12.1	-4.6	-38.2	-5.9	-23.6	-16.6	-7.2	-30.2	-93	-36.1	-13
cash-flows.row.acquisitions-net	1.26	15.8	-704.6	188.8	77.9	30	0.5	-153.2	-2.8	1.6	-22.9	-111.1	-51.9	-175.1	-622.7	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	-6122.14	-8033	-10846.8	-11925	-11831.1	-8776.7	-6306.3	-7587.6	-7845.7	-6922.3	-5807.4	-2108.8	-40.9	-45.4	-78.4	0	0	-163.2	0	-2.1	0	0	-31	0	0	0
cash-flows.row.sales-maturities-of-investments	6052	7662.9	12347.9	10753.2	11034.2	8793.8	6326.5	7528.3	7884.5	6937.7	5814.1	2111.8	40.8	72.9	72.1	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-investing-activites	-1.21	0.3	22.6	1.1	0.1	-0.5	-28.9	-1.2	-195.5	-38.8	-0.9	43.6	0.1	0.1	0.1	0.1	0.3	0	7.3	6.7	5.6	5.3	8.3	5.6	1.6	0
cash-flows.row.net-cash-used-for-investing-activites	-267.38	-575.2	319.3	-1200.1	-862.9	-23.5	-51.8	-273.6	-236.9	-159.3	-111.2	-306.6	-153.3	-176.2	-687.4	-12	-4.3	-201.4	1.4	-18.9	-11	-1.9	-52.9	-87.4	-34.5	-13
cash-flows.row.debt-repayment	0	-5.5	-60	-60	0	0	0	-0.7	0	0	0	-22.6	-20	-23.9	0	0	0	-46	-165.3	-180.2	-163.3	-74	-28.3	-105.8	-6	0
cash-flows.row.common-stock-issued	0	0	139.7	-0.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	-199.6	-59.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-280.16	-140.2	-283.2	-169.6	-123.9	-124.6	-121.5	-0.1	-25.7	-99.1	-16.1	-40.6	-24.5	-84.7	0	0	0	0	-17.8	-20.3	-18.9	-19.6	-20.5	-14.2	-9.6	-13.2
cash-flows.row.other-financing-activites	-368.02	-84.4	-59.1	907.2	-44.1	-16.7	-16.2	-12.4	1.6	-12.1	3.6	391.6	16.7	22	690.1	0	0.2	8.4	160.5	138.9	197	90.3	109.7	219.7	71.5	28.6
cash-flows.row.net-cash-used-provided-by-financing-activities	-368.2	-230.1	-462.2	617.6	-168	-141.2	-137.7	-13.2	-24.1	-111.2	-12.5	328.4	-27.7	-86.5	690.1	0	0.2	-37.6	-22.6	-61.6	14.8	-3.3	60.9	99.8	55.9	15.4
cash-flows.row.effect-of-forex-changes-on-cash	817.23	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	552.16	464.7	634.8	288.6	-337	404.7	308.4	235.3	173.8	94.8	89.6	205.8	-14.1	-132.7	203.2	50.1	31.3	-3.7	-38.9	-63	-46.3	22.7	11.4	-24.8	88.8	16.8
cash-flows.row.cash-at-end-of-period	6370.97	2825.2	2360.4	1707.9	1419.2	1756.2	1351.5	1043.1	807.8	634	539.2	449.6	214.6	228.7	349.3	129.1	79	0	3.7	42.6	105.5	151.9	129.1	117.7	142.4	53.7
cash-flows.row.cash-at-beginning-of-period	5818.81	2360.4	1725.6	1419.2	1756.2	1351.5	1043.1	807.8	634	539.2	449.6	243.8	228.7	361.3	146.1	79	47.7	3.7	42.6	105.5	151.9	129.1	117.7	142.4	53.7	36.9
cash-flows.row.operating-cash-flow	698.58	1270	777.7	871.1	694	569.5	497.9	522.1	434.8	365.3	213.4	184	166.9	130.1	200.6	62.1	35.4	235.3	-17.6	17.6	-50.1	28	3.4	-37.1	67.4	14.5
cash-flows.row.capital-expenditure	-197.29	-221.1	-499.8	-218.2	-144.1	-70.1	-43.6	-59.9	-77.4	-137.5	-94.1	-242.1	-101.5	-28.6	-58.5	-12.1	-4.6	-38.2	-5.9	-23.6	-16.6	-7.2	-30.2	-93	-36.1	-13
cash-flows.row.free-cash-flow	501.3	1048.9	277.9	652.9	549.9	499.3	454.3	462.2	357.4	227.7	119.3	-58.1	65.5	101.5	142	50.1	30.8	197.1	-23.6	-6	-66.7	20.8	-26.8	-130.1	31.3	1.4

Kasumiaruande rida

Renhe Pharmacy Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.044%. 000650.SZ brutokasum on teatatud 1886.94. Ettevõtte tegevuskulud on 947.34, mille muutus võrreldes eelmise aastaga on 1.870%. Kulud amortisatsioonikulud on 117.15, mis on 1.189% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 947.34, mis näitab 1.870% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.081% kasvu võrreldes eelmise aastaga. Tegevustulu on 953.26, mis näitab -0.081% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.136%. Eelmise aasta puhaskasum oli 574.44.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005	2003	2001	1999	1997	1995	1993
income-statement-row.row.total-revenue	5126.13	5153.2	4935.8	4106.1	4581.2	4403.4	3843.8	3567.1	2523.8	2253.2	1799.4	2087.5	2207.7	1366.8	982.7	876.5	778.7	24.9	267.1	280.4	281.6	220.8	225.1	236.1	236	192.6	136.3	169.5	160.8	132.2	126.3
income-statement-row.row.cost-of-revenue	3179.36	3266.3	3061.4	2456.1	2642.7	2510.6	2347.2	2261.1	1399.2	1222.7	999.5	1265.2	1338.4	659.8	311.6	445.1	481.5	35.4	261.5	281.4	239.6	189.2	234	195.6	190.4	147.5	108.4	130	109	85.5	85.4
income-statement-row.row.gross-profit	1946.77	1886.9	1874.3	1650	1938.5	1892.8	1496.6	1306	1124.6	1030.5	799.9	822.3	869.3	707	671.1	431.3	297.1	-10.4	5.6	-1	42	31.6	-8.9	40.5	45.7	45.2	27.9	39.5	51.8	46.7	40.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	40.41	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	86.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	552.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	275.74	269.6	224.8	194.5	219.6	2.4	0.8	9.7	13.3	8.8	14.7	36.3	9.3	1.7	-0.7	2.4	6.8	-48	7.8	18.2	10.6	11.6	17.1	10.5	4	-0.1	0.2	3.6	0.9	1	0.7
income-statement-row.row.operating-expenses	928.5	947.3	929.9	864.3	1124.9	1130.3	942.1	752	577.6	608.6	515.9	515.9	490	420	460.4	334	244.1	-209.3	130.5	72.7	138.8	19.5	14.5	15.7	8.5	6.6	6.6	8	8.6	8.8	6.8
income-statement-row.row.cost-and-expenses	4107.86	4213.6	3991.4	3320.3	3767.5	3640.9	3289.3	3013	1976.8	1831.4	1515.4	1781.1	1828.4	1079.8	772	779.1	725.6	-173.9	392	354.1	378.3	208.7	248.5	211.3	198.9	154.1	115	137.9	8.6	8.8	6.8
income-statement-row.row.interest-income	23.21	24.2	56.7	10.6	37.9	33.2	16.9	1.5	6	3.2	2.6	4.3	3.5	4	1.8	0.4	0.2	5.4	7.3	6.7	5.7	5	8.3	0	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	0.38	0.4	1	1.4	0.1	0.5	0.5	0.1	5.9	0	0	1.2	1.1	0.7	0.4	1.4	1	26.1	20.1	20.3	19.6	19.6	15.4	10	8.1	4.3	5	12.8	17.2	17.8	14.9
income-statement-row.row.selling-and-marketing-expenses	552.45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	0.93	0.3	-2.5	-12.9	-2.3	-7.2	16.1	4.8	25.2	0.5	-7.5	38.7	11.4	2.7	2.1	0	4.9	-69.8	-20.6	-13.9	-14.3	-15	-7.4	-10.2	-8.8	-4.4	-5.2	-10.4	-17.2	-17.8	-14.9
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	275.74	269.6	224.8	194.5	219.6	2.4	0.8	9.7	13.3	8.8	14.7	36.3	9.3	1.7	-0.7	2.4	6.8	-48	7.8	18.2	10.6	11.6	17.1	10.5	4	-0.1	0.2	3.6	0.9	1	0.7
income-statement-row.row.total-operating-expenses	0.93	0.3	-2.5	-12.9	-2.3	-7.2	16.1	4.8	25.2	0.5	-7.5	38.7	11.4	2.7	2.1	0	4.9	-69.8	-20.6	-13.9	-14.3	-15	-7.4	-10.2	-8.8	-4.4	-5.2	-10.4	-17.2	-17.8	-14.9
income-statement-row.row.interest-expense	0.38	0.4	1	1.4	0.1	0.5	0.5	0.1	5.9	0	0	1.2	1.1	0.7	0.4	1.4	1	26.1	20.1	20.3	19.6	19.6	15.4	10	8.1	4.3	5	12.8	17.2	17.8	14.9
income-statement-row.row.depreciation-and-amortization	51.47	173.6	79.3	77.8	106.8	91.8	87.2	80.3	74.1	69	64.2	56.2	29.4	26.8	20.6	8.6	8.3	20.8	22.3	27.4	27.1	26.9	23.5	18.6	12.8	11.5	4.6	11.5	-34.7	-28.9	-25.9
income-statement-row.row.ebitda-caps	1112.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1060.78	953.3	1036.9	860.5	826.2	752.9	569.8	550.2	560.2	415.3	262.3	309	381.4	288.2	213.7	96	51.1	179.6	-122.2	-68.8	-100.5	9	-13.2	25.7	32.9	34.3	16.7	20	26.1	20.1	19.1
income-statement-row.row.income-before-tax	1061.71	953.5	1034.4	847.6	823.9	755.3	570.6	558.9	572.2	422.3	276.5	345.1	390.7	289.6	212.8	97.4	57.9	130.3	-129.9	-69.1	-100.5	8.8	-13.5	25.4	32.6	34.2	16.5	22.4	26.1	20.1	19.1
income-statement-row.row.income-tax-expense	264.64	242	234.5	190	204.6	171.2	129.5	128.1	136.7	98.5	60.5	68.9	84.9	63.9	47.3	27.2	18.7	-43.8	-0.4	6.4	5.3	4.5	-0.7	3.6	4.9	5.9	0.2	7.4	8.6	6.6	6.3
income-statement-row.row.net-income	658.36	574.4	665	580.2	537.8	506.5	380.2	372.4	391.3	300.9	194.2	255.5	300.4	219.5	165.5	70.2	39.2	130.3	-129.9	-69.1	-100.5	8.8	-12.7	21.8	27.7	28.3	16.4	15	17.5	13.5	12.8